Inventor
SHI SONGYUAN
US35 patents
⚠️ This page may combine multiple inventors who share the name “SHI SONGYUAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PLEXXIKON INC
21 patentsUS9771363B2Sep 26, 2017
Heterocyclic compounds and uses thereof
PLEXXIKON INC34 citations98
US9469640B2Oct 18, 2016
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC44 citations98
US10370374B2Aug 6, 2019
Heterocyclic compounds and uses thereof
PLEXXIKON INC17 citations94
US9975894B2May 22, 2018
Heterocyclic compounds and uses thereof
PLEXXIKON INC20 citations94
US9814714B2Nov 14, 2017
Kinase modulation, and indications therefor
PLEXXIKON INC22 citations94
US9718847B2Aug 1, 2017
Heterocyclic compounds and uses thereof
PLEXXIKON INC33 citations94
US9617267B2Apr 11, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC38 citations94
US9873700B2Jan 23, 2018
Compounds for kinase modulation, and indications therefor
PLEXXIKON INC20 citations93
US9844539B2Dec 19, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC20 citations93
US9856259B2Jan 2, 2018
Heterocyclic compounds and uses thereof
PLEXXIKON INC20 citations86
US10899761B2Jan 26, 2021
Heterocyclic compounds and uses thereof
PLEXXIKON INC4 citations84
US10647716B2May 12, 2020
Heterocyclic compounds and uses thereof
PLEXXIKON INC7 citations84
US10426760B2Oct 1, 2019
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC6 citations84
US10227357B2Mar 12, 2019
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC7 citations84
US10160747B2Dec 25, 2018
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC8 citations83
US10421761B2Sep 24, 2019
Compounds for kinase modulation, and indications therefor
PLEXXIKON INC6 citations82
US11337976B2May 24, 2022
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC1 citations73
US10519177B2Dec 31, 2019
Heterocyclic compounds and uses thereof
PLEXXIKON INC4 citations73
US10703757B2Jul 7, 2020
Compounds and methods for CDK8 modulation and indications therefor
PLEXXIKON INC4 citations71
US12076322B2Sep 3, 2024
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC0 citations63
US12509444B2Dec 30, 2025
Compounds and methods for CD73 modulation and indications therefor
PLEXXIKON INC0 citations48
TELIK INC
4 patentsUS7262182B2Aug 28, 2007
Sulfonylethyl phosphorodiamidates
TELIK INC12 citations84
US7071231B2Jul 4, 2006
Naphthalene ureas as glucose uptake enhancers
TELIK INC2 citations61
US6458998B1Oct 1, 2002
Naphthalene ureas as glucose uptake enhancers
TELIK INC1 citations50
US6653321B1Nov 25, 2003
Naphthylsulfonic acids and related compounds as glucose uptake agonists
TELIK INC0 citations37
IBRAHIM PRABHA N
3 patentsUS8673928B2Mar 18, 2014
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N60 citations98
US8198273B2Jun 12, 2012
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N65 citations98
US8153641B2Apr 10, 2012
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N51 citations94
Opna Bio SA
3 patentsUS12116365B2Oct 15, 2024
Heterocyclic compounds and uses thereof
Opna Bio SA0 citations61
US12202818B2Jan 21, 2025
Compounds and methods for CD73 modulation and indications therefor
Opna Bio SA0 citations58
US11807626B2Nov 7, 2023
Compounds and methods for CD73 modulation and indications therefor
Opna Bio SA1 citations58